©
University of Oxford Images / Public Affairs Directorate
Since 2021, we have conducted serosurveys among populations residing within health and demographic surveillance sites in Kilifi, Nairobi, Kisumu and Siaya. Samples collected during the surveys are tested for IgG antibodies using cutting edge assays such as a multiplex vaccine-preventable disease panel (diphtheria, pertussis, tetanus, measles, mumps, rubella, varicella) and an arbovirus multiplex panel (chikungunya, dengue, and Rift Valley Fever).
8th May, the KEMIS Steering Committee reviewed the progress, findings, and achievements of the Project. On 9th May we held a Dissemination Workshop with representation from a wide range of stakeholders including the Ministry of Health, Kilifi, Nairobi, Kiambu, Laikipia and Machakos Counties. We shared findings from the KEMIS project and received valuable input from the delegates including recommendations on potential approaches for expanding the reach and sustainability of serosurveillance in Kenya.